CDK4 and melanoma: Variants in CDKN2A, CDK4, and MC1R—such as G101W, A148T, and R24C—have been associated with melanoma in populations from Poland [32], Spain [33], and the United Kingdom (UK) [34] as well as in Brazilian [35,36] and Austrian populations [37].